Results 271 to 280 of about 222,802 (316)
Some of the next articles are maybe not open access.

New anticoagulants

Current Opinion in Hematology, 2006
Abstract Traditional anticoagulant drugs, including unfractionated heparin and warfarin, have several limitations. New anticoagulants have been developed that target a single coagulation factor and have predictable dose-response relationships. These include direct thrombin inhibitors and factor Xa inhibitors.
AGNELLI, Giancarlo, BECATTINI, Cecilia
openaire   +6 more sources

Anticoagulation

Clinical Obstetrics and Gynecology, 1998
Outpatient management of women requiring treatment and prophylaxis against thromboembolic conditions during pregnancy and the postpartum period requires a coordinated effort between the patient, her obstetrician and, in certain cases, a hematologic consultant.
H L, Brown, R A, Bobrowski
openaire   +2 more sources

Anticoagulation clinics and the monitoring of anticoagulant therapy

International Journal of Cardiology, 1988
Patients attending an anticoagulation clinic were studied to delineate predisposing risk factors for bleeding and thromboembolic episodes. Seventy-three patients were observed for a total of 921.8 patient-treatment months. The mean duration of treatment was 12.6 months (range 3-36 months).
R, Charney   +3 more
openaire   +2 more sources

Novel anticoagulants and the future of anticoagulation

Thrombosis Research, 2009
Since its discovery during the first half of the 20th century by biochemists at the University of Wisconsin, warfarin (along with other vitamin K antagonists) has remained the only oral anticoagulant available to patients at risk for thromboembolism. After nearly 6 decades in clinical practice, we have learned much about warfarin. Although it is highly
openaire   +2 more sources

The Future of Anticoagulation

Seminars in Respiratory and Critical Care Medicine, 2008
The conventional management of thrombotic disorders is based on the use of heparin, oral anticoagulants, and aspirin. The development of low molecular weight heparins and the synthesis of heparinomimetics such as the chemically synthesized pentasaccharide represent a refined use of heparin.
Debra A, Hoppensteadt   +3 more
openaire   +2 more sources

Anticoagulants in Pregnancy

Obstetrical & Gynecological Survey, 2006
Pregnancy is a hypercoagulable state that increases the risk of thromboembolic events. These risks may be further increased in the presence of an acquired or inherited thrombophilia. Thrombophilias have been associated with both maternal and fetal complications.
Andra H, James   +2 more
openaire   +2 more sources

Anticoagulation therapy

British Journal of Hospital Medicine, 2008
Every junior doctor will have to prescribe some form of anticoagulation therapy for their patients. Foundation year 1 doctors should be familiar with the use of warfarin and heparin as anticoagulants, and be able to prescribe them appropriately, safely and effectively. The use of these drugs is outlined here.
R, Shakur   +3 more
openaire   +2 more sources

Anticoagulant Rodenticides

Toxicological Reviews, 2005
Anticoagulant pesticides are used widely in agricultural and urban rodent control. The emergence of warfarin-resistant strains of rats led to the introduction of a new group of anticoagulant rodenticides variously referred to as 'superwarfarins', 'single dose' or 'long-acting'.
Barbara E, Watt   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy